<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">At data cut in August 2016, 3795 patients with lymphoid B cell neoplasms had been recruited into the TLN; 180 patients had incomplete basic medical data or withdrew consent. Of the 3615 evaluable patients, 490 were diagnosed with MM and 359 of them had not received a stem cell transplant. The present analysis focuses on 285 non-transplant patients with MM recruited at the start of first-line treatment (Fig.Â 
 <xref rid="Fig1" ref-type="fig">1</xref>).
</p>
